Fermicon 7/Somnugen (Canada)

This page contains information on Fermicon 7/Somnugen for veterinary use.
The information provided typically includes the following:
  • Fermicon 7/Somnugen Indications
  • Warnings and cautions for Fermicon 7/Somnugen
  • Direction and dosage information for Fermicon 7/Somnugen

Fermicon 7/Somnugen

This treatment applies to the following species:
Manufacturer: Boehringer

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D-Haemophilus Somnus Bacterin-Toxoid

Veterinary Use Only

Fermicon 7/Somnugen Indications

For vaccination of healthy, susceptible cattle as an aid in the reduction of diseases caused by Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, Cl. perfringens types C and D, and Haemophilus somnus.

Dosage: Using aseptic technique, inject 5 mL intramuscularly or subcutaneously. Repeat in 21 to 28 days and once annually.

Precautions

Store in dark at 2-7°C. Do not freeze. Shake well. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur. Antidote: Epinephrine.

Preservative: Phenol.

Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.

U.S. Veterinary License No. 124

Manufactured for: Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4

10 Doses/50 mL

18707-05

50 Doses/250 mL

18708-05

NAC No.: 12300203

BOEHRINGER INGELHEIM (CANADA) LTD.
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
Customer Care No.:   800-567-1885
Technical Services No.:   1-877-565-5501
Website:   www.boehringer-ingelheim.ca
Every effort has been made to ensure the accuracy of the Fermicon 7/Somnugen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web2)